Estados financieros detallados de Plus Therapeutics, Inc. (PSTV): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Plus Therapeutics, Inc. registró ingresos de $5.2M en el último ejercicio fiscal, con un CAGR de 5 años del 76.7%.
Márgenes de los últimos 12 meses: margen bruto 61.5%, margen operativo -6.3%, margen neto -6.2%.
Al precio actual de $3.87, PSTV presenta beneficios negativos (P/E no significativo) y un ROE del -5.60%. La capitalización bursátil es de $9M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $11.4M | $6.4M | $3.0M | $7.0M | $303000 | 0 | $224000 | $4.9M | $5.8M | $5.2M |
| Coste de Ventas | $2.7M | $1.3M | $1.1M | 0 | $2.7M | $66000 | $712000 | $9.7M | $852000 | $445000 |
| Beneficio Bruto | $8.7M | $5.1M | $1.8M | $7.0M | -$2.4M | -$66000 | -$488000 | -$4.8M | $5.0M | $4.8M |
| I+D | $16.2M | $13.4M | $5.5M | $5.4M | $3.5M | $5.3M | $9.7M | $9.7M | $10.6M | $8.4M |
| Generales y Administrativos | $12.2M | $11.2M | $6.2M | $5.3M | $6.4M | $6.9M | $9.5M | $8.5M | $9.9M | $12.1M |
| Gastos Operativos | $28.4M | $25.8M | $10.8M | $10.7M | $7.2M | $12.4M | $19.2M | $8.5M | $19.7M | $20.1M |
| Beneficio Operativo | -$19.7M | -$20.7M | -$8.8M | -$3.7M | -$9.6M | -$12.5M | -$19.7M | -$13.3M | -$14.7M | -$15.3M |
| EBITDA | -$18.3M | -$18.5M | -$6.6M | -$532000 | -$8.4M | -$12.0M | -$18.9M | -$12.3M | -$8.4M | -$18.3M |
| Gastos por Intereses | $2.6M | $2.0M | $1.9M | $1.9M | $1.1M | $932000 | $711000 | $395000 | $3.7M | $3.6M |
| Beneficio Antes de Impuestos | -$22.0M | -$22.7M | -$8.9M | -$3.3M | -$8.2M | -$13.4M | -$20.3M | -$13.3M | -$13.0M | -$22.4M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$22.0M | -$22.7M | -$12.6M | -$10.9M | -$8.2M | -$13.4M | -$20.3M | -$13.3M | -$13.0M | -$22.4M |
| BPA | $-240000000.00 | $-131345500.00 | $-32617500.00 | $-3101250.00 | $-697500.00 | $-444500.00 | $-288750.00 | $-106000.00 | $-48.75 | $-7.19 |
| BPA Diluido | $-240000000.00 | $-131345500.00 | $-32617500.00 | $-3452500.00 | $-697500.00 | $-444500.00 | $-288750.00 | $-106000.00 | $-58.50 | $-7.19 |
| Acciones en Circulación (Diluidas) | $692 | $17 | $0 | $4 | $12 | $32 | $70 | $126 | $308030 | $3.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $1.4M | $1.4M | $1.0M | $411000 |
| Beneficio Bruto | $1.3M | $1.3M | $919000 | -$919000 |
| Beneficio Operativo | -$4.5M | -$5.7M | -$7.1M | -$9.1M |
| EBITDA | -$4.3M | -$2.3M | -$6.8M | -$9.1M |
| Beneficio Neto | -$4.4M | -$5.7M | -$6.9M | -$9.0M |
| BPA | $-1030.00 | $-1.04 | $-1.05 | $-1.31 |
| BPA Diluido | $-1.00 | $-1.05 | $-1.05 | $-1.31 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $12.6M | $9.6M | $5.3M | $17.6M | $8.3M | $18.4M | $18.1M | $8.6M | $76000 | $8.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.5M | 0 |
| Cuentas por Cobrar | $1.3M | $257000 | $233000 | $1.3M | $59000 | $7000 | 0 | 0 | $571000 | 0 |
| Inventario | $3.7M | $3.2M | $107000 | $107000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $18.7M | $14.9M | $9.6M | $19.8M | $9.2M | $19.7M | $21.8M | $9.8M | $5.3M | $15.2M |
| Inmovilizado Material | $1.2M | $3.1M | $2.3M | $3.0M | $2.5M | $1.8M | $1.6M | $1.1M | $521000 | $327000 |
| Fondo de Comercio | $3.9M | $3.9M | $372000 | $372000 | $372000 | $372000 | $372000 | $372000 | $372000 | $372000 |
| Activos Intangibles | $8.4M | $7.2M | 0 | 0 | $86000 | $51000 | $94000 | $42000 | $469000 | $333000 |
| Activos Totales | $34.6M | $31.6M | $24.0M | $23.2M | $12.1M | $22.0M | $23.9M | $11.4M | $6.6M | $16.3M |
| Cuentas por Pagar | $1.3M | $1.3M | $721000 | $327000 | $789000 | $2.6M | $8.4M | $4.8M | $9.5M | $3.3M |
| Deuda a Corto | $6.6M | $13.6M | $14.2M | $11.1M | $6.3M | $1.6M | $1.7M | $4.0M | $3.3M | $806000 |
| Pasivos Corrientes | $12.5M | $18.4M | $17.6M | $14.5M | $8.5M | $5.9M | $11.9M | $10.7M | $15.6M | $12.3M |
| Deuda a Largo | $11.0M | 0 | 0 | 0 | 0 | $5.0M | $3.8M | 0 | 0 | $15000 |
| Pasivos Totales | $23.6M | $18.6M | $18.8M | $22.1M | $9.1M | $11.1M | $17.4M | $12.7M | $15.6M | $12.3M |
| Reservas | -$379.1M | -$401.7M | -$414.4M | -$425.3M | -$433.5M | -$446.9M | -$467.2M | -$480.5M | -$493.5M | -$515.9M |
| Patrimonio Neto | $11.0M | $13.0M | $5.2M | $1.2M | $3.0M | $10.8M | $6.4M | -$1.3M | -$8.9M | $4.0M |
| Deuda Total | $17.6M | $13.6M | $14.2M | $12.0M | $7.0M | $7.0M | $5.8M | $4.2M | $3.4M | $821000 |
| Deuda Neta | $5.1M | $4.1M | $8.9M | -$5.6M | -$1.4M | -$11.4M | -$12.4M | -$4.4M | -$239000 | -$7.9M |
| Capital Circulante | $6.2M | -$3.5M | -$7.9M | $5.3M | $636000 | $13.9M | $10.0M | -$893000 | -$10.3M | $2.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $13.3M | $8.8M | $3.0M | $2.4M |
| Activos Totales | $18.7M | $16.3M | $19.9M | $14.0M |
| Pasivos Totales | $13.6M | $12.3M | $8.0M | $8.6M |
| Patrimonio Neto | $5.1M | $4.0M | $12.0M | $5.5M |
| Deuda Total | $6.4M | $821000 | $725000 | $44000 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$22.0M | -$22.7M | -$12.6M | -$10.9M | -$8.2M | -$13.4M | -$20.3M | -$13.3M | -$13.0M | -$22.4M |
| Amortizaciones | $1.2M | $2.2M | $2.0M | $896000 | $366000 | $395000 | $619000 | $628000 | $723000 | $445000 |
| Compensación en Acciones | $1.1M | $753000 | $355000 | $127000 | $247000 | $606000 | $606000 | $569000 | $550000 | $1.5M |
| Cambio en Capital Circulante | -$772000 | -$1.0M | -$1.0M | -$938000 | $119000 | $1.2M | $5.6M | -$1.1M | $3.2M | -$6.0M |
| Flujo de Caja Operativo | -$19.5M | -$18.1M | -$12.0M | -$5.9M | -$8.4M | -$10.3M | -$13.0M | -$12.9M | -$10.6M | -$20.8M |
| Inversiones (CapEx) | -$67000 | -$1.5M | -$133000 | -$67000 | -$493000 | -$144000 | -$759000 | -$160000 | -$146000 | -$67000 |
| Adquisiciones | 0 | 0 | 0 | $5.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | -$2.1M | 0 | 0 | 0 | 0 | 0 | -$126000 | -$374000 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$19.6M | -$19.6M | -$12.1M | -$6.0M | -$8.9M | -$10.4M | -$13.7M | -$13.0M | -$10.7M | -$20.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.5M | -$6.3M | -$6.2M | -$7.1M |
| Inversiones (CapEx) | -$27000 | -$30000 | -$818000 | -$499000 |
| Flujo de Caja Libre | -$2.6M | -$6.3M | -$7.1M | -$7.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $527000 | $713000 | $1.0M | $830000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -43.7% | -53.5% | +134.6% | -95.7% | -100.0% | | +2093.3% | +18.5% | -10.5% |
| Crecimiento Beneficio Neto (anual) | | -2.9% | +44.3% | +13.8% | +24.3% | -62.6% | -51.3% | +34.3% | +2.5% | -72.5% |
| Crecimiento BPA (anual) | | +45.3% | +75.2% | +90.5% | +77.5% | +36.3% | +35.0% | +63.3% | +100.0% | +85.3% |
| Cambio en Acciones (anual) | | -97.5% | -97.3% | +696.1% | +219.9% | +173.0% | +117.2% | +79.4% | +245074.6% | +910.4% |
| Crecimiento FCF (anual) | | -0.1% | +38.3% | +50.7% | -49.5% | -16.8% | -31.7% | +5.2% | +17.8% | -94.8% |
| Margen Bruto | 76.1% | 79.4% | 61.5% | 100.0% | -791.1% | | -217.9% | -97.2% | 85.4% | 91.5% |
| Margen Operativo | -173.2% | -322.6% | -293.7% | -52.3% | -3163.0% | | -8800.0% | -271.1% | -252.3% | -293.5% |
| Margen EBITDA | -160.6% | -288.3% | -220.5% | -7.6% | -2784.5% | | -8416.1% | -250.2% | -144.3% | -351.7% |
| Margen Neto | -193.7% | -353.9% | -423.5% | -155.6% | -2719.8% | | -9051.3% | -271.0% | -222.8% | -429.4% |
| Margen FCF | -172.2% | -306.1% | -405.9% | -85.4% | -2946.2% | | -6129.9% | -264.8% | -183.7% | -399.8% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-28338.55 | $-1136004.67 | $-26117342.54 | $-1618400.95 | $-756041.04 | $-323347.13 | $-196117.92 | $-103560.26 | $-34.74 | $-6.70 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $692 | $17 | $0 | $4 | $12 | $32 | $70 | $126 | $265610 | $3.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -560.21% |
| Rentabilidad sobre capital invertido | -317.58% |
| Rentabilidad sobre activos | -137.13% |
| Margen bruto | 61.53% |
| Margen operativo | -628.12% |
| Margen neto | -620.70% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 1.37 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -44.86 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.59 | -1.78 |
| P/VC | 17.82 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.85 | 9.98 |
| P/V | 17.21 | 0.15 | 0.00 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 1.31 | 7.65 |
| Margen Bruto | 76.1% | 79.4% | 61.5% | 100.0% | -791.1% | 0.0% | -217.9% | -97.2% | 85.4% | 91.5% |
| Margen Operativo | -173.2% | -322.6% | -293.7% | -52.3% | -3163.0% | 0.0% | -8800.0% | -271.1% | -252.3% | -293.5% |
| Margen Neto | -193.7% | -353.9% | -423.5% | -155.6% | -2719.8% | 0.0% | -9051.3% | -271.0% | -222.8% | -429.4% |